Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/42534
Title: Too much of a good thing? Experimental evidence suggests prolonged exposure to hCG is detrimental to endometrial receptivity.
Authors: Salamonsen L.A.;Evans J.
Institution: (Evans, Salamonsen) Prince Henry's Institute, Monash Medical Centre, PO Box 5152, Clayton, Melbourne, VIC 3168, Australia (Evans, Salamonsen) Faculty of Medicine, Nursing and Health Sciences, Monash University, VIC 3800, Australia
Issue Date: 5-Jun-2013
Copyright year: 2013
Publisher: Oxford University Press
Place of publication: United Kingdom
Publication information: Human Reproduction. 28 (6) (pp 1610-1619), 2013. Date of Publication: June 2013.
Journal: Human Reproduction
Abstract: STUDY QUESTION Does prolonged exposure of the endometrium to hCG, as experienced after ovulation induction in an assisted reproduction technology (ART) cycle, affect functional measures of endometrial receptivity? SUMMARY ANSWER Prolonged endometrial hCG exposure detrimentally affects the manner in which the endometrium can respond to hCG secreted by the blastocyst. WHAT IS KNOWN ALREADY Prolonged hCG exposure down-regulates endometrial LH-CG receptor (LHCGR) expression in a baboon model. HCG exposure during the proliferative phase of oocyte-donation cycles and frozen embryo transfer cycles is associated with a lower pregnancy rate. STUDY DESIGN, SIZE, DURATION LHCGR was examined in endometria of women undergoing ART cycles (GnRH agonist/antagonist) and across the menstrual cycle in normally cycling fertile women. To determine whether prolonged hCG exposure affects the subsequent endometrial response to hCG, endometrial epithelial cells (HES cell line and primary cultures of human endometrial epithelial cells) were exposed to a low dose of hCG (0.5-5 IU) for up to 5 days, to mimic the chronic exposure during an ART cycle, and subsequently exposed to an acute 'blastocyst mimic' dose of hCG (20 IU).PARTICIPANTS/ MATERIALS, SETTING, METHODS Endometrial tissues were collected at hCG + 2 (n = 37) from women undergoing ART between August 2006 and August 2008, and across the cycle from women with known fertility (n = 40). LHCGR localization and staining intensity were determined by immunohistochemistry and semi-quantitative scoring. HES cells were treated with hCG as above and analyzed for LHCGR localization (immunocytochemistry), phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 (western immunoblotting), adhesion to trophoblast-like matrices (adhesion assays) and tight junction integrity (trans-epithelial resistance assessment). MAIN RESULTS AND THE ROLE OF CHANCE Endometrial epithelial LHCGR staining was significantly lower in women stimulated with a GnRH agonist protocol who did not become pregnant in that cycle versus the natural menstrual cycle (P < 0.05). Chronic low-dose hCG exposure in vitro mediated a down-regulation and internalization of the LHCGR in endometrial epithelial cells. Prolonged exposure to chronic low-dose hCG (3-5 days) abrogated ERK 1/2 phosphorylation, adhesion to extracellular matrices and changes in tight junction integrity in response to a subsequent acute high dose (20 IU) of hCG. LIMITATIONS, REASONS FOR CAUTION Studies using cell lines and primary cultures of cells in vitro are not fully representative of the complex endometrial milieu in vivo. WIDER IMPLICATIONS OF THE FINDINGS These data reinforce the clinical observations that precocious or prolonged hCG exposure may detrimentally affect endometrial receptivity and provide a mechanistic basis for these clinical findings. The data appear to support the notion that in women for whom ART has not succeeded, a different, minimally stimulated approach without exposure to exogenous hCG may improve outcomes. STUDY FUNDING/COMPETING INTEREST(S) The authors have no competing interests. © 2013 The Author. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1093/humrep/det055
PubMed URL: 23515188 [http://www.ncbi.nlm.nih.gov/pubmed/?term=23515188]
ISSN: 0268-1161
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/42534
Type: Article
Subjects: human cell
human tissue
immunohistochemistry
infertility therapy
intracytoplasmic sperm injection
menstrual cycle
nonhuman
oral contraception
protein phosphorylation
receptor down regulation
tight junction
Western blotting
cetrorelix
*chorionic gonadotropin
gonadorelin agonist
gonadorelin antagonist
luteinizing hormone receptor/ec [Endogenous Compound]
mitogen activated protein kinase 1/ec [Endogenous Compound]
mitogen activated protein kinase 3/ec [Endogenous Compound]
nafarelin acetate
recombinant follitropin
oocyte donation
pregnancy rate
protein expression
protein localization
animal experiment
article
blastocyst
cell adhesion
cell culture
controlled study
embryo transfer
*endometrium
epithelium cell
female
human
human
human cell
human tissue
immunohistochemistry
infertility therapy
intracytoplasmic sperm injection
menstrual cycle
nonhuman
oocyte donation
oral contraception
pregnancy rate
protein expression
protein localization
protein phosphorylation
receptor down regulation
tight junction
article
animal experiment
Western blotting
blastocyst
cell adhesion
cell culture
controlled study
embryo transfer
*endometrium
epithelium cell
female
Appears in Collections:Articles

Show full item record

Page view(s)

18
checked on Sep 1, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.